Keyphrases
Hepatic Function
100%
HIV Patients
100%
Protease Inhibitors
100%
Inflammation Markers
100%
Microbial Translocation
100%
Lipid Abnormalities
100%
Plasma Metabolomics
100%
Antiretroviral Therapy
66%
Lipids
50%
Lipid Modification
33%
Bile Acids
33%
Gene Set Enrichment Analysis
33%
Interferon-α (IFN-α)
16%
Inflammation
16%
Serostatus
16%
Interleukin-6
16%
Metabolism
16%
Dysregulated
16%
Therapeutic Strategies
16%
CD4 Count
16%
Healthy Controls
16%
Nuclear Receptor
16%
False Discovery Rate
16%
Hepatitis C
16%
Protein Function
16%
Principal Coordinate Analysis (PCoA)
16%
Hepatic Fibrosis
16%
Metabolic Disorders
16%
Random Forest
16%
Advanced Disease
16%
Non-invasive Biomarkers
16%
CD4 Nadir
16%
Metabolic Abnormalities
16%
Lipopolysaccharide
16%
Lipid Biomarkers
16%
Non-alcoholic Fatty Liver Disease (NAFLD)
16%
Nucleotide Metabolism
16%
L-carnitine
16%
Innate Immune Response
16%
Mass Spectrometry
16%
Untargeted Metabolomics
16%
Lipopolysaccharide-binding Protein
16%
Bilirubin
16%
Polyunsaturated Fatty Acids
16%
Mitochondrial Dysfunction
16%
Lipid Metabolites
16%
Eicosanoids
16%
Amino Acid Metabolism
16%
Liquid Chromatography
16%
Unsupervised Hierarchical Clustering
16%
MetaboAnalyst
16%
Hepatic Dysfunction
16%
Pathway Mapping
16%
Partial Least Squares Discriminant Analysis (PLS-DA)
16%
Gas Chromatography
16%
YKL-40
16%
Fibrosis-4 (FIB-4)
16%
Metabolic Signature
16%
HCV Co-infection
16%
Gas Mass
16%
Co-relationship
16%
Signature Mapping
16%
Sulfated Steroids
16%
Biochemistry, Genetics and Molecular Biology
Human Immunodeficiency Virus
100%
Lipid
100%
Liver Function
100%
Protease Inhibitor
100%
Metabolomics
100%
Blood Plasma
100%
Metabolite
57%
Bile Acid
28%
Interleukin 6
14%
Metabolic Pathway
14%
CD4 Lymphocyte Count
14%
Nuclear Receptor
14%
Principal Component Analysis
14%
Nucleotide Metabolism
14%
Mass Spectrometry
14%
Lipopolysaccharide Binding Protein
14%
Eicosanoid
14%
Amino Acid Metabolism
14%
Random Forest
14%
Mitochondrial Disorder
14%
Focused Ion Beam
14%
Interferon
14%
Lipopolysaccharide
14%
Polyunsaturated Fatty Acid
14%
Bilirubin
14%
Gas Chromatography
14%
Pharmacology, Toxicology and Pharmaceutical Science
HIV
100%
Inflammation
100%
Proteinase Inhibitor
100%
Bile Acid
33%
Interleukin 6
16%
Interferon
16%
Nonalcoholic Fatty Liver
16%
Liver Fibrosis
16%
Hepatitis C
16%
Amino Acid
16%
Mixed Infection
16%
Lipopolysaccharide Binding Protein
16%
Bilirubin
16%
Lipopolysaccharide
16%
Polyunsaturated Fatty Acid
16%
Cell Nucleus Receptor
16%
Acylcarnitine
16%
Liver Dysfunction
16%
Icosanoid
16%
Focused Ion Beam
16%
Diseases
16%
Immunology and Microbiology
Human Immunodeficiency Virus
100%
Blood Plasma
100%
Liver Function
100%
Metabolite
66%
interferon
16%
Interleukin 6
16%
CD4 Lymphocyte Count
16%
Hepatitis C
16%
Coinfection
16%
Lipopolysaccharide Binding Protein
16%
Random Forest
16%
Liquid Chromatography
16%
Non-Alcoholic Fatty Liver Disease
16%
Gas Chromatography
16%
Amino Acid Metabolism
16%
Nucleotide Metabolism
16%
Fatty Acid
16%